nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ADRB2—polycystic ovary syndrome	0.612	1	CbGaD
Metoprolol—SLC22A2—Metformin—polycystic ovary syndrome	0.211	1	CbGbCtD
Metoprolol—Emotional distress—Metformin—polycystic ovary syndrome	0.0048	0.0829	CcSEcCtD
Metoprolol—Respiratory distress—Metformin—polycystic ovary syndrome	0.00321	0.0555	CcSEcCtD
Metoprolol—Heartburn—Metformin—polycystic ovary syndrome	0.00296	0.0512	CcSEcCtD
Metoprolol—Lightheadedness—Metformin—polycystic ovary syndrome	0.00182	0.0315	CcSEcCtD
Metoprolol—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00152	0.0262	CcSEcCtD
Metoprolol—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00137	0.0236	CcSEcCtD
Metoprolol—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00135	0.0234	CcSEcCtD
Metoprolol—Breast disorder—Metformin—polycystic ovary syndrome	0.00134	0.0231	CcSEcCtD
Metoprolol—Cramp muscle—Metformin—polycystic ovary syndrome	0.00133	0.023	CcSEcCtD
Metoprolol—Angina pectoris—Metformin—polycystic ovary syndrome	0.00125	0.0215	CcSEcCtD
Metoprolol—Sweating increased—Metformin—polycystic ovary syndrome	0.00125	0.0215	CcSEcCtD
Metoprolol—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00108	0.0186	CcSEcCtD
Metoprolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.00105	0.108	CrCbGaD
Metoprolol—Bradycardia—Metformin—polycystic ovary syndrome	0.00104	0.018	CcSEcCtD
Metoprolol—Rhinitis—Metformin—polycystic ovary syndrome	0.00103	0.0177	CcSEcCtD
Metoprolol—Hepatitis—Metformin—polycystic ovary syndrome	0.00102	0.0177	CcSEcCtD
Metoprolol—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00101	0.0174	CcSEcCtD
Metoprolol—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00101	0.0174	CcSEcCtD
Metoprolol—Eye disorder—Metformin—polycystic ovary syndrome	0.000957	0.0165	CcSEcCtD
Metoprolol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00095	0.0164	CcSEcCtD
Metoprolol—Angiopathy—Metformin—polycystic ovary syndrome	0.000929	0.016	CcSEcCtD
Metoprolol—Immune system disorder—Metformin—polycystic ovary syndrome	0.000925	0.016	CcSEcCtD
Metoprolol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000923	0.0159	CcSEcCtD
Metoprolol—Bevantolol—ADRA1A—polycystic ovary syndrome	0.000903	0.0937	CrCbGaD
Metoprolol—Pindolol—ADRB3—polycystic ovary syndrome	0.000899	0.0933	CrCbGaD
Metoprolol—Flatulence—Metformin—polycystic ovary syndrome	0.000878	0.0152	CcSEcCtD
Metoprolol—Dysgeusia—Metformin—polycystic ovary syndrome	0.000873	0.0151	CcSEcCtD
Metoprolol—Muscle spasms—Metformin—polycystic ovary syndrome	0.000857	0.0148	CcSEcCtD
Metoprolol—Vision blurred—Metformin—polycystic ovary syndrome	0.00084	0.0145	CcSEcCtD
Metoprolol—Syncope—Metformin—polycystic ovary syndrome	0.000799	0.0138	CcSEcCtD
Metoprolol—Palpitations—Metformin—polycystic ovary syndrome	0.000788	0.0136	CcSEcCtD
Metoprolol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000783	0.0135	CcSEcCtD
Metoprolol—Hypertension—Metformin—polycystic ovary syndrome	0.00077	0.0133	CcSEcCtD
Metoprolol—Chest pain—Metformin—polycystic ovary syndrome	0.000759	0.0131	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000754	0.013	CcSEcCtD
Metoprolol—Oedema—Metformin—polycystic ovary syndrome	0.000727	0.0126	CcSEcCtD
Metoprolol—Shock—Metformin—polycystic ovary syndrome	0.000716	0.0124	CcSEcCtD
Metoprolol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000713	0.0123	CcSEcCtD
Metoprolol—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000712	0.0123	CcSEcCtD
Metoprolol—Skin disorder—Metformin—polycystic ovary syndrome	0.000707	0.0122	CcSEcCtD
Metoprolol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000703	0.0121	CcSEcCtD
Metoprolol—Metipranolol—ADRB2—polycystic ovary syndrome	0.000684	0.071	CrCbGaD
Metoprolol—Hypotension—Metformin—polycystic ovary syndrome	0.00068	0.0117	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000663	0.0115	CcSEcCtD
Metoprolol—Paraesthesia—Metformin—polycystic ovary syndrome	0.000653	0.0113	CcSEcCtD
Metoprolol—Dyspnoea—Metformin—polycystic ovary syndrome	0.000649	0.0112	CcSEcCtD
Metoprolol—Somnolence—Metformin—polycystic ovary syndrome	0.000647	0.0112	CcSEcCtD
Metoprolol—Dyspepsia—Metformin—polycystic ovary syndrome	0.00064	0.0111	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000628	0.0109	CcSEcCtD
Metoprolol—Fatigue—Metformin—polycystic ovary syndrome	0.000627	0.0108	CcSEcCtD
Metoprolol—Constipation—Metformin—polycystic ovary syndrome	0.000622	0.0107	CcSEcCtD
Metoprolol—Sotalol—ADRB2—polycystic ovary syndrome	0.00061	0.0633	CrCbGaD
Metoprolol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000599	0.0104	CcSEcCtD
Metoprolol—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000595	0.0103	CcSEcCtD
Metoprolol—Urticaria—Metformin—polycystic ovary syndrome	0.000578	0.00998	CcSEcCtD
Metoprolol—Abdominal pain—Metformin—polycystic ovary syndrome	0.000575	0.00994	CcSEcCtD
Metoprolol—Chlorphenesin—CYP19A1—polycystic ovary syndrome	0.000553	0.0573	CrCbGaD
Metoprolol—Esmolol—ADRB2—polycystic ovary syndrome	0.000543	0.0564	CrCbGaD
Metoprolol—Bevantolol—ADRB2—polycystic ovary syndrome	0.000537	0.0557	CrCbGaD
Metoprolol—Asthenia—Metformin—polycystic ovary syndrome	0.000522	0.00902	CcSEcCtD
Metoprolol—Pruritus—Metformin—polycystic ovary syndrome	0.000515	0.00889	CcSEcCtD
Metoprolol—Diarrhoea—Metformin—polycystic ovary syndrome	0.000498	0.0086	CcSEcCtD
Metoprolol—Propranolol—ADRB3—polycystic ovary syndrome	0.00049	0.0509	CrCbGaD
Metoprolol—Dizziness—Metformin—polycystic ovary syndrome	0.000481	0.00831	CcSEcCtD
Metoprolol—Betaxolol—ADRB2—polycystic ovary syndrome	0.000478	0.0496	CrCbGaD
Metoprolol—Atenolol—ADRB2—polycystic ovary syndrome	0.000474	0.0492	CrCbGaD
Metoprolol—Vomiting—Metformin—polycystic ovary syndrome	0.000463	0.00799	CcSEcCtD
Metoprolol—Bisoprolol—ADRB2—polycystic ovary syndrome	0.000462	0.0479	CrCbGaD
Metoprolol—Rash—Metformin—polycystic ovary syndrome	0.000459	0.00792	CcSEcCtD
Metoprolol—Dermatitis—Metformin—polycystic ovary syndrome	0.000458	0.00792	CcSEcCtD
Metoprolol—Headache—Metformin—polycystic ovary syndrome	0.000456	0.00787	CcSEcCtD
Metoprolol—Acebutolol—ADRB2—polycystic ovary syndrome	0.000438	0.0454	CrCbGaD
Metoprolol—Oxprenolol—ADRB2—polycystic ovary syndrome	0.000434	0.0451	CrCbGaD
Metoprolol—Nausea—Metformin—polycystic ovary syndrome	0.000432	0.00747	CcSEcCtD
Metoprolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.000397	0.0412	CrCbGaD
Metoprolol—Pindolol—ADRB2—polycystic ovary syndrome	0.000342	0.0355	CrCbGaD
Metoprolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000186	0.0193	CrCbGaD
Metoprolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.00016	0.0166	CrCbGaD
Metoprolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	5.43e-05	0.000497	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.43e-05	0.000496	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.39e-05	0.000493	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	5.39e-05	0.000492	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.39e-05	0.000492	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	5.37e-05	0.000491	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	5.33e-05	0.000487	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.31e-05	0.000485	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.27e-05	0.000482	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.25e-05	0.00048	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.23e-05	0.000478	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	5.13e-05	0.000469	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.12e-05	0.000468	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.09e-05	0.000465	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	5.06e-05	0.000463	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	5.03e-05	0.00046	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	5.03e-05	0.00046	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.98e-05	0.000455	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.97e-05	0.000454	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	4.96e-05	0.000453	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	4.91e-05	0.000449	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	4.91e-05	0.000449	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	4.85e-05	0.000444	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	4.8e-05	0.000439	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	4.68e-05	0.000428	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	4.66e-05	0.000426	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.63e-05	0.000423	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	4.63e-05	0.000423	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	4.63e-05	0.000423	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	4.58e-05	0.000419	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.57e-05	0.000418	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	4.57e-05	0.000417	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.53e-05	0.000414	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.52e-05	0.000413	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.52e-05	0.000413	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.42e-05	0.000404	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	4.3e-05	0.000393	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	4.29e-05	0.000392	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.27e-05	0.00039	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	4.22e-05	0.000386	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	4.18e-05	0.000382	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	4.13e-05	0.000377	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	4.13e-05	0.000377	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.1e-05	0.000375	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.08e-05	0.000373	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.05e-05	0.00037	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	4.04e-05	0.000369	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.03e-05	0.000368	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.01e-05	0.000367	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	3.98e-05	0.000364	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	3.98e-05	0.000364	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.97e-05	0.000363	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	3.95e-05	0.000361	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	3.88e-05	0.000355	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	3.88e-05	0.000355	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.88e-05	0.000355	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.86e-05	0.000353	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.83e-05	0.00035	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.78e-05	0.000345	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.77e-05	0.000344	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	3.76e-05	0.000344	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.74e-05	0.000342	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.71e-05	0.000339	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	3.68e-05	0.000336	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	3.67e-05	0.000335	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	3.66e-05	0.000334	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	3.66e-05	0.000334	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	3.64e-05	0.000333	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.63e-05	0.000332	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	3.59e-05	0.000328	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.59e-05	0.000328	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	3.52e-05	0.000322	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.52e-05	0.000321	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.51e-05	0.000321	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.47e-05	0.000318	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.47e-05	0.000317	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.46e-05	0.000316	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	3.44e-05	0.000314	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.4e-05	0.000311	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	3.4e-05	0.00031	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.4e-05	0.00031	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.39e-05	0.00031	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	3.36e-05	0.000307	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	3.33e-05	0.000305	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.28e-05	0.0003	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	3.26e-05	0.000298	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.25e-05	0.000297	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	3.22e-05	0.000295	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.22e-05	0.000295	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.22e-05	0.000294	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.21e-05	0.000293	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	3.2e-05	0.000292	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	3.16e-05	0.000289	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	3.15e-05	0.000288	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.15e-05	0.000288	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	3.13e-05	0.000286	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.09e-05	0.000282	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.08e-05	0.000281	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	3.07e-05	0.00028	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.04e-05	0.000278	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	3.02e-05	0.000276	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	3e-05	0.000274	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.99e-05	0.000273	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.98e-05	0.000272	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.94e-05	0.000269	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.94e-05	0.000269	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.94e-05	0.000269	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	2.92e-05	0.000267	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.91e-05	0.000266	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	2.88e-05	0.000263	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	2.82e-05	0.000257	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.77e-05	0.000253	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	2.75e-05	0.000252	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	2.69e-05	0.000246	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.68e-05	0.000244	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.63e-05	0.000241	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.63e-05	0.00024	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.62e-05	0.00024	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.62e-05	0.000239	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	2.61e-05	0.000238	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—TH—polycystic ovary syndrome	2.59e-05	0.000237	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.58e-05	0.000235	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	2.56e-05	0.000234	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	2.55e-05	0.000233	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.53e-05	0.000232	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.52e-05	0.00023	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.5e-05	0.000229	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.47e-05	0.000226	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.47e-05	0.000226	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.42e-05	0.000221	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.42e-05	0.000221	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.4e-05	0.00022	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.37e-05	0.000217	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	2.37e-05	0.000217	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	2.37e-05	0.000217	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.36e-05	0.000215	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	2.34e-05	0.000214	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.33e-05	0.000213	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.31e-05	0.000211	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	2.29e-05	0.000209	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.28e-05	0.000209	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.28e-05	0.000209	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.26e-05	0.000207	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.25e-05	0.000206	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.24e-05	0.000205	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.23e-05	0.000204	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	2.21e-05	0.000202	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.21e-05	0.000202	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.2e-05	0.000201	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.16e-05	0.000197	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.15e-05	0.000197	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.13e-05	0.000195	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.12e-05	0.000194	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	2.12e-05	0.000193	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	2.11e-05	0.000193	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.1e-05	0.000192	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.09e-05	0.000191	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.07e-05	0.00019	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	2.07e-05	0.000189	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.04e-05	0.000186	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	2.04e-05	0.000186	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.04e-05	0.000186	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	2.02e-05	0.000184	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.01e-05	0.000183	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.99e-05	0.000182	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.99e-05	0.000182	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.97e-05	0.00018	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.93e-05	0.000176	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.91e-05	0.000175	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.9e-05	0.000174	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.87e-05	0.000171	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.86e-05	0.00017	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.86e-05	0.00017	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.83e-05	0.000167	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.82e-05	0.000166	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.82e-05	0.000166	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.81e-05	0.000166	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.8e-05	0.000165	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.79e-05	0.000164	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.78e-05	0.000163	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	1.78e-05	0.000163	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.77e-05	0.000162	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.76e-05	0.000161	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.75e-05	0.00016	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.74e-05	0.000159	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.73e-05	0.000158	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	1.7e-05	0.000156	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.68e-05	0.000154	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	1.68e-05	0.000153	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.66e-05	0.000152	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.66e-05	0.000152	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.64e-05	0.00015	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.54e-05	0.000141	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.49e-05	0.000136	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	1.46e-05	0.000133	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.46e-05	0.000133	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.45e-05	0.000133	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	1.45e-05	0.000132	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.43e-05	0.00013	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	1.43e-05	0.00013	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—INS—polycystic ovary syndrome	1.42e-05	0.00013	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.42e-05	0.000129	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.41e-05	0.000129	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.38e-05	0.000126	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.33e-05	0.000122	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.3e-05	0.000119	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.3e-05	0.000119	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.3e-05	0.000118	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.25e-05	0.000114	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.25e-05	0.000114	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.22e-05	0.000112	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.22e-05	0.000111	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.2e-05	0.00011	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.2e-05	0.00011	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.16e-05	0.000106	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.14e-05	0.000105	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.13e-05	0.000103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.12e-05	0.000102	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.1e-05	0.000101	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.09e-05	9.96e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	1.07e-05	9.78e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	9.54e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	9.49e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	9.98e-06	9.11e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	9.84e-06	8.99e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	9.74e-06	8.9e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.21e-06	8.42e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	9.17e-06	8.38e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	9.01e-06	8.23e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	8.09e-06	7.39e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	7.98e-06	7.29e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—INS—polycystic ovary syndrome	7.93e-06	7.25e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	7.9e-06	7.21e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.87e-06	7.19e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—POMC—polycystic ovary syndrome	7.79e-06	7.11e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—INS—polycystic ovary syndrome	7.74e-06	7.08e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.7e-06	7.03e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	7.44e-06	6.8e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	7.34e-06	6.7e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	7.3e-06	6.67e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	5.44e-06	4.97e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	5.32e-06	4.86e-05	CbGpPWpGaD
